Tripletail Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$664K Sell
710
-52
-7% -$52.7K 0.91% 25
2025
Q4
$819K Sell
762
-22
-3% -$21K 1.04% 21
2025
Q3
$663K Sell
784
-2
-0.3% -$1.49K 0.78% 27
2025
Q2
$505K Buy
+786
New +$611K 0.72% 32

Other funds holding LLY

Tripletail Wealth Management's LLY Position: Q1 2026 in Review

Tripletail Wealth Management reduced its Eli Lilly (LLY) stake by 6.8% in Q1 2026, selling an estimated $52.7K and leaving 710 shares worth $664K. The position accounts for 0.91% of the portfolio, ranked #25.

Tripletail Wealth Management first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $819K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Tripletail Wealth Management held 710 shares of Eli Lilly worth $664K as of Q1 2026.
  • Tripletail Wealth Management sold 52 Eli Lilly shares in Q1 2026, an estimated $52.7K.
  • Eli Lilly made up 0.91% of Tripletail Wealth Management's portfolio in Q1 2026, its #25 holding.
  • Tripletail Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Tripletail Wealth Management's Eli Lilly position peaked at $819K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tripletail Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.